In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients-Reference-Cited by-同舟云学术

In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients

Published:2017-08-29 Issue:3 Volume:21 Page:401-412
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Kuboki Yasutoshi,Schatz Christoph A.,Koechert Karl,Schubert Sabine,Feng Janine,Wittemer-Rump Sabine,Ziegelbauer Karl,Krahn Thomas,Nagatsuma Akiko Kawano,Ochiai Atsushi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s10120-017-0758-x/fulltext.html

Reference53 articles.

1. Song H, Zhu J, Lu D. Molecular-targeted first-line therapy for advanced gastric cancer. Cochrane Database Syst Rev. 2016;7:CD011461.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

4. Bilici A. Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World J Gastroenterol. 2014;20:3905–15.

5. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging targets in gastroesophageal adenocarcinoma: what the future looks like;Therapeutic Advances in Medical Oncology;2023-01

2. FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract;Journal of Cancer Research and Clinical Oncology;2022-11-23

3. Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?;Cells;2022-10-10

4. Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer;Frontiers in Oncology;2022-09-06

5. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?;Life;2022-01-07